APT Medical Inc. (SHA:688617)

Market Cap	35.51B
Revenue (ttm)	2.41B
Net Income (ttm)	768.31M
Shares Out	141.03M
EPS (ttm)	5.44
PE Ratio	46.26
Forward PE	34.47
Dividend	1.21 (0.48%)
Ex-Dividend Date	Jun 19, 2025

Volume	1,198,390
Average Volume	902,347
Open	256.50
Previous Close	255.91
Day's Range	249.02 - 257.87
52-Week Range	228.22 - 337.20
Beta	-0.26
RSI	47.43
Earnings Date	Mar 25, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, del...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.